Figure 7.
Figure 7. Immunophenotype of 19-28z CAR T-cell products infused and relationship to events (progression or death) and toxicity. Open circles represent data points for each subjects’ graft products’ immunophenotype proportion. (A) Events. Subjects whose infused CAR T cells were composed of a greater percentage of naive-like (CD45RA+, CCR7+) cells were more likely to experience an event for both CD4+ (P = .02) and CD8+ (P = .04) CAR+ subsets. No significant difference was seen in other immunophenotypic subsets: central memory (CD45RA−, CCR7+), effector memory (CD45RA−, CCR7−), and effector (CD45RA+, CCR7−) T cells. (B) Toxicity. No significant differences were seen in any immunophenotypic subsets of the 19-28z CAR T graft product between subjects who did or did not experience toxicity.

Immunophenotype of 19-28z CAR T-cell products infused and relationship to events (progression or death) and toxicity. Open circles represent data points for each subjects’ graft products’ immunophenotype proportion. (A) Events. Subjects whose infused CAR T cells were composed of a greater percentage of naive-like (CD45RA+, CCR7+) cells were more likely to experience an event for both CD4+ (P = .02) and CD8+ (P = .04) CAR+ subsets. No significant difference was seen in other immunophenotypic subsets: central memory (CD45RA, CCR7+), effector memory (CD45RA, CCR7), and effector (CD45RA+, CCR7) T cells. (B) Toxicity. No significant differences were seen in any immunophenotypic subsets of the 19-28z CAR T graft product between subjects who did or did not experience toxicity.

Close Modal

or Create an Account

Close Modal
Close Modal